Affordability of SGLT2i may contribute to the low prescription rate in CKD.
A study of Chinese patients revealed that the increased risk of chronic kidney disease progression was present regardless of baseline kidney function.
Investigators observed the association in a study of 63 Japanese men undergoing hemodialysis.
The 4-variable KFRE score still underestimated the risk for end-stage kidney disease, especially for Black patients.
Ultrasound-guided radiofrequency ablation may result in a shorter hospital stay compared with parathyroidectomy.
In a study of patients receiving dialysis, 1 in 5 patients fully vaccinated against the SARS-CoV-2 coronavirus, which causes COVID-19, had undetectable levels of antibodies 5 to 6 months after vaccination.
Atrasentan lowers the risk for a composite of kidney failure, doubling of serum creatinine, or kidney death consistently across subgroups of urinary albumin-creatinine ratio and estimated glomerular filtration rate.
A reduced-dose steroid regimen in high-risk IgaN may offer the best balance of risks vs benefits, an investigator stated.
Avoiding unnecessary medications in CKD might reduce the risks for adverse outcomes, investigators suggested.
A mediation analysis was also conducted to analyze the degree to which kidney decline contributes to potassium-related mortality.